Ketogenic diet in treatment of Pediatric Refractory Epilepsy - Efficacy and potential Adverse Effects, A Review
DOI:
https://doi.org/10.12775/QS.2026.63.73351Keywords
ketogenic diet, KD, pediatric epilepsy, pediatric refractory epilepsy, MAD, MCT, LGITAbstract
Background. Epilepsy affects 0,5-1% of children. It is more frequently resistant to anti-seizure drugs compared to the adult population. Ketogenic diet is a high-fat, low-carbohydrate nutrition style that has been widely used and researched as treatment for refractory pediatric epilepsy, giving a relatively safe alternative to more hazardous and invasive forms of seizure therapy.
Aim. Discussion of efficacy and potential adverse effects of the ketogenic diet in treatment of pediatric refractory epilepsy, with additional overview of different ketogenic diet forms.
Material and methods. A narrative review of the PubMed database using the following keywords was performed: ketogenic diet, KD, pediatric epilepsy, pediatric refractory epilepsy. The findings were analysed in terms of relevance, studied population and researched outcomes. Studies from the year 2015 or older were excluded.
Results. Ketogenic diet was identified as highly effective in pediatric refractory epilepsy. Examined research shows a significant seizure frequency reduction in studied populations. Comparison between the classic ketogenic diet and its alternatives is inconsistent, but the efficacy seems to be comparable. The diet is reported to have frequent side effects, most commonly gastrointestinal, however they are usually mild and easy to prevent or treat.
Conclusions. Ketogenic diet seems to be a relatively low-risk, effective option for treatment of refractory pediatric epilepsy. Possible adverse effects in majority should not be a reason for withdrawal.
References
1. Borowicz-Reutt, K., Krawczyk, M., & Czernia, J. (2024). Ketogenic Diet in the Treatment of Epilepsy. In Nutrients (Vol. 16, Number 9). https://doi.org/10.3390/nu16091258
2. D’Andrea Meira, I., Romão, T. T., Do Prado, H. J. P., Krüger, L. T., Pires, M. E. P., & Da Conceição, P. O. (2019). Ketogenic diet and epilepsy: What we know so far. Frontiers in Neuroscience, 13(JAN). https://doi.org/10.3389/fnins.2019.00005
3. Dyńka, D., Kowalcze, K., & Paziewska, A. (2022). The Role of Ketogenic Diet in the Treatment of Neurological Diseases. In Nutrients (Vol. 14, Number 23). MDPI. https://doi.org/10.3390/nu14235003
4. Enkhtuy, B., Kwon, H. E., & Kim, H. D. (2019). Advances in ketogenic diet therapies in pediatric epilepsy. In Annals of Child Neurology (Vol. 27, Number 4, pp. 105–112). Korean Child Neurology Society. https://doi.org/10.26815/acn.2019.00192
5. Haridas, B., Testino, A., & Kossoff, E. H. (2025). Ketogenic diet therapy for the treatment of pediatric epilepsy. Epileptic Disorders, 27(2), 144–155. https://doi.org/10.1002/epd2.20320
6. Kim, J. A., Yoon, J. R., Lee, E. J., Lee, J. S., Kim, J. T., Kim, H. D., & Kang, H. C. (2016). Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia, 57(1), 51–58. https://doi.org/10.1111/epi.13256
7. Ko, A., Kwon, H. E., & Kim, H. D. (2022). Updates on the ketogenic diet therapy for pediatric epilepsy. In Biomedical Journal (Vol. 45, Number 1, pp. 19–26). Elsevier B.V. https://doi.org/10.1016/j.bj.2021.11.003
8. Kossoff, E. H., Zupec-Kania, B. A., Auvin, S., Ballaban-Gil, K. R., Christina Bergqvist, A. G., Blackford, R., Buchhalter, J. R., Caraballo, R. H., Cross, J. H., Dahlin, M. G., Donner, E. J., Guzel, O., Jehle, R. S., Klepper, J., Kang, H. C., Lambrechts, D. A., Liu, Y. M. C., Nathan, J. K., Nordli, D. R., … Wirrell, E. C. (2018). Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open, 3(2), 175–192. https://doi.org/10.1002/epi4.12225
9. Lyons, L., Schoeler, N. E., Langan, D., & Cross, J. H. (2020). Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis. Epilepsia, 61(6), 1261–1281. https://doi.org/10.1111/epi.16543
10. Martin-McGill, K. J., Bresnahan, R., Levy, R. G., & Cooper, P. N. (2020). Ketogenic diets for drug-resistant epilepsy. In Cochrane Database of Systematic Reviews (Vol. 2020, Number 6). John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD001903.pub5
11. Murakami, M., & Tognini, P. (2022). Molecular Mechanisms Underlying the Bioactive Properties of a Ketogenic Diet. In Nutrients (Vol. 14, Number 4). MDPI. https://doi.org/10.3390/nu14040782
12. Parveen, D., Jain, V., Kannan, D., Mandava, P., Urazbayeva, M., Andrew Sanjeev Jogie, J., Patel, P., McCarthy, K., Wilson, M., Patel, U., Hsieh, Y.-C., Chavda, D., & Thakker, Z. (2024). Systematic Review Advances in Ketogenic Diet Therapies in Pediatric Epilepsy: A Systematic Review.
13. Skrobas, U., Duda, P., Bryliński, Ł., Drożak, P., Pelczar, M., & Rejdak, K. (2022). Ketogenic Diets in the Management of Lennox-Gastaut Syndrome—Review of Literature. In Nutrients (Vol. 14, Number 23). MDPI. https://doi.org/10.3390/nu14234977
14. Sondhi, V., Agarwala, A., Pandey, R. M., Chakrabarty, B., Jauhari, P., Lodha, R., Toteja, G. S., Sharma, S., Paul, V. K., Kossoff, E., & Gulati, S. (2020). Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet among Children with Drug-Resistant Epilepsy: A Randomized Clinical Trial. JAMA Pediatrics, 174(10), 944–951. https://doi.org/10.1001/jamapediatrics.2020.2282
15. Sourbron, J., Klinkenberg, S., van Kuijk, S. M. J., Lagae, L., Lambrechts, D., Braakman, H. M. H., & Majoie, M. (2020). Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis. In Child’s Nervous System (Vol. 36, Number 6, pp. 1099–1109). Springer. https://doi.org/10.1007/s00381-020-04578-7
16. Verrotti, A., Iapadre, G., Di Francesco, L., Zagaroli, L., & Farello, G. (2020). Diet in the treatment of epilepsy: What we know so far. In Nutrients (Vol. 12, Number 9, pp. 1–19). MDPI AG. https://doi.org/10.3390/nu12092645
17. Wang, M., Zhao, F., Sun, L., Yu, Y., & Zhang, H. (2024). Ketogenic diets therapy in the management of epileptic spasms syndrome. In Frontiers in Pediatrics (Vol. 12). Frontiers Media SA. https://doi.org/10.3389/fped.2024.1472982
18. Wells, J., Swaminathan, A., Paseka, J., & Hanson, C. (2020). Efficacy and safety of a ketogenic diet in children and adolescents with refractory epilepsy—a review. In Nutrients (Vol. 12, Number 6, pp. 1–19). MDPI AG. https://doi.org/10.3390/nu12061809
19. Youngson, N. A., Morris, M. J., & Ballard, B. (2017). The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metabolism-altering drugs. In Seizure (Vol. 52, pp. 15–19). W.B. Saunders Ltd. https://doi.org/10.1016/j.seizure.2017.09.005
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Weronika Kaczmarek, Karolina Szeląg, Jan Damian, Mikołaj Brzeźniak, Emilia Fitz, Julia Mokracka, Kacper Gil, Justyna Daniek, Krzystof Drelich, Aleksander Karbowniczek, Filip Kręcina, Alicja Grabarczyk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 75
Number of citations: 0
